FN1 and gastric cancer: By promoting fibronectin 1 downregulation and thereby inactivating AKT signaling activity, miR-613 can suppress nasopharyngeal carcinoma cell angiogenic activity [67], and it can further render gastric cancer cells more sensitive to cisplatin treatment by suppressing Sex-determining region Y-box 9 expression [68].